• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Artificial pancreas lowers the risk of overnight hypoglycemia in children

bys25qthea
March 1, 2013
in Chronic Disease, Gastroenterology
Reading Time: 3 mins read
Artificial pancreas lowers the risk of overnight hypoglycemia in children
Share on FacebookShare on Twitter

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Overnight hypoglycemia was less likely with an artificial pancreas compared to a sensor-augmented insulin pump in children with type 1 diabetes. 

2. There was significantly less variation in overnight glycemic levels using the artificial pancreas.

This multi-national crossover study measured the efficacy of an artificial pancreas compared to a sensor-augmented insulin pump in children with type 1 diabetes at a camp. The authors of the study found that artificial pancreas use was associated with a lower risk of hypoglycemia.

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

Some strengths of the study are its size and generalizability given that it was conducted in three different countries.  There are, however, several limitations to this study. First, subjects used the artificial pancreas for only one night. Clinically, these devices should be worn at all times during the day. Calibration of the artificial pancreas and the control group was performed every three hours. Clinically, these devices would only be calibrated three times a day. Future research should try to replicate the use of these devices in real clinical situations.

Click to read the study in NEJM

[/tab]

[tab]

Image: PD

1. Overnight hypoglycemia was less likely with an artificial pancreas compared to a sensor-augmented insulin pump in children with type 1 diabetes. 

2. There was significantly less variation in overnight glycemic levels using the artificial pancreas.

This [prospective crossover] study compared the efficacy of an artificial pancreas device (close looped continuous glucose sensory and insulin pump) to a sensor-augmented insulin pump in 54 children with Type 1 diabetes at a two day sleep-away camp in three different countries. Subjects were randomized into either the artificial pancreas group the first night, and then the sensor-augmented insulin pump the next, or vice versa. Primary endpoints were the number of hypoglycemic events, duration of hypoglycemia and mean overnight glucose levels. The devices were worn from 5 pm to 7 am.

There was a significant decrease in the number of hypoglycemic events, as well as the time in hypoglycemia on the nights of the artificial pancreas compared to control. Furthermore, there was significantly less variation in glucose levels overnight while using the artificial pancreas compared to the control. However, there was no difference in mean overnight glucose levels.

In sum: This multi-national crossover study measured the efficacy of an artificial pancreas compared to a sensor-augmented insulin pump in children with type 1 diabetes at a camp. The authors of the study found that artificial pancreas use was associated with a lower risk of hypoglycemia.

Some strengths of the study are its size and generalizability given that it was conducted in three different countries.  There are, however, several limitations to this study. First, subjects used the artificial pancreas for only one night. Clinically, these devices should be worn at all times during the day. Calibration of the artificial pancreas and the control group was performed every three hours. Clinically, these devices would only be calibrated three times a day. Future research should try to replicate the use of these devices in real clinical situations.

Click to read the study in NEJM

By Jeremy Chan and Mitalee Patil

More from this author: Selumetinib increases the uptake of radioiodine in patients with metastatic thyroid cancer refractory to radioiodine, A fractional two-dose regimen of the polio vaccine presents a low-cost alternative to the current schedule

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: artificial pancreasdiabeteshypoglycemiapancreas
Previous Post

CABG leads to fewer MIs and repeat revascularization vs. stenting

Next Post

Clinic intervention reduces pregnancy risk behaviors in vulnerable youth

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
Clinic intervention reduces pregnancy risk behaviors in vulnerable youth

Clinic intervention reduces pregnancy risk behaviors in vulnerable youth

After-school program increases physical activity in overweight children

After-school program increases physical activity in overweight children

Hep B reactivation common after liver resection for HBV-related hepatocellular carcinoma

Hep B reactivation common after liver resection for HBV-related hepatocellular carcinoma

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.